Longeveron (LGVN) Current Assets (2021 - 2026)
Longeveron (LGVN) recorded quarterly Current Assets of $16.9 million in Q1 2026, up 209.21% quarter-over-quarter from $5.5 million in Q4 2025, and up 10.34% on a YoY basis from $15.3 million in Q1 2025.
Longeveron (LGVN) Current Assets (2021 - 2026) Analysis & Trends
Longeveron's Current Assets history runs 6 years deep, the most recent figure standing at $16.9 million for Q1 2026.
- In Q1 2026, Current Assets rose 10.34% year-over-year to $16.9 million; the TTM figure through Mar 2026 stood at $16.9 million (up 10.34% YoY), while the FY2025 annual figure was $5.5 million, down 72.22% from the prior year.
- Current Assets was $16.9 million for Q1 2026 at Longeveron, up from $5.5 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $23.8 million in Q3 2024 to a low of $3.8 million in Q1 2024.
- Historically, Current Assets has averaged $12.6 million across 5 years, with a median of $12.3 million in 2024.
- Biggest YoY gain for Current Assets was 371.19% in 2024; the steepest drop was 74.73% in 2024.
- A 5-year view of Current Assets shows it stood at $20.3 million in 2022, then tumbled by 71.16% to $5.8 million in 2023, then soared by 235.57% to $19.6 million in 2024, then slumped by 72.22% to $5.5 million in 2025, then soared by 209.21% to $16.9 million in 2026.
- The last three Current Assets figures came in at $16.9 million (Q1 2026), $5.5 million (Q4 2025), and $10.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 37.31 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 521.86 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 10.37 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.25 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 3.59 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 7.63 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 11.73 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 600.85 Mn |
| 10 | Longeveron | 20.35 Bn | 20.33 Bn | 264,000.00 | 16.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.86 Mn |
| Dec 31, 2025 | 5.45 Mn |
| Sep 30, 2025 | 10.34 Mn |
| Jun 30, 2025 | 11.27 Mn |
| Mar 31, 2025 | 15.28 Mn |
| Dec 31, 2024 | 19.62 Mn |
| Sep 30, 2024 | 23.77 Mn |
| Jun 30, 2024 | 13.41 Mn |
| Mar 31, 2024 | 3.76 Mn |
| Dec 31, 2023 | 5.85 Mn |
| Sep 30, 2023 | 5.04 Mn |
| Jun 30, 2023 | 10.29 Mn |
| Mar 31, 2023 | 14.87 Mn |
| Dec 31, 2022 | 20.28 Mn |
| Dec 31, 2021 | 35.38 Mn |